Advertisement
Screener

TENET HEALTHCARE CORP (THC) Overview

TENET HEALTHCARE CORP (THC) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 9.84; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 8.01; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 3.86; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 3.14; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$153.30$175.05$199.87$228.22$260.59$297.552025-11-062026-11-06$35.62$54.46$83.27$127.30$194.63$297.552021-11-082026-11-06$10.46$20.43$39.91$77.97$152.32$297.552016-11-072026-11-06$3.42$8.35$20.40$49.84$121.78$297.552006-11-062026-11-06$3.42$8.96$23.45$61.42$160.85$421.231980-03-172026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$283.38
Previous close
$257.60
Change
$25.78
Change (%)
10.01%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

THC
+29.63%
S&P 500
(m)

1 year

THC
+28.03%
S&P 500
(m)

3 years

THC
+290.94%
S&P 500
(m)

5 years

THC
+275.31%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 9.84

3.064.806.548.2810.0231 Mar 2025: estimate (m); actual 4.2731 Mar 2025(m)30 Jun 2025: estimate (m); actual 3.1430 Jun 2025(m)30 Sept 2025: estimate (m); actual 3.8630 Sept 2025(m)31 Mar 2026: estimate (m); actual 8.0131 Mar 2026(m)30 Jun 2026: estimate (m); actual 9.8430 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)9.84(m)(m)
1 Jan 202631 Mar 2026(m)8.01(m)(m)
1 Jul 202530 Sept 2025(m)3.86(m)(m)
1 Apr 202530 Jun 2025(m)3.14(m)(m)
1 Jan 202531 Mar 2025(m)4.27(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 15.49

3.7111.0018.3025.5932.8831 Dec 2021: estimate (m); actual 8.4231 Dec 2021(m)31 Dec 2022: estimate (m); actual 3.7931 Dec 2022(m)31 Dec 2023: estimate (m); actual 5.7131 Dec 2023(m)31 Dec 2024: estimate (m); actual 32.7031 Dec 2024(m)31 Dec 2025: estimate (m); actual 15.4931 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)15.49(m)(m)
1 Jan 202431 Dec 2024(m)32.70(m)(m)
1 Jan 202331 Dec 2023(m)5.71(m)(m)
1 Jan 202231 Dec 2022(m)3.79(m)(m)
1 Jan 202131 Dec 2021(m)8.42(m)(m)

Revenue vs. Earnings

USD

No complete retained periods.

31 Dec 2025 ■ Revenue 21.31B ■ Earnings 2.37B — Profit margin 11.11%

-2.56B4.2%6.25B9.7%15.06B15.2%23.87B20.7%31 Dec 2022: revenue 19.17B; earnings 1.00B; profit margin 5.22%31 Dec 202231 Dec 2023: revenue 20.56B; earnings 1.31B; profit margin 6.38%31 Dec 202331 Dec 2024: revenue 20.68B; earnings 4.06B; profit margin 19.66%31 Dec 202431 Dec 2025: revenue 21.31B; earnings 2.37B; profit margin 11.11%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$283.38(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$283.38High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning THC

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Index membership
(m)
Employees
98.00K
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
803.96K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-1.70%*
Total return · month
-3.45%*
Total return · quarter
37.63%*
Total return · half year
34.27%*
Total return · year to date
29.63%*
Total return · 1 year
28.03%*
Total return · 3 years
290.94%*
Total return · 5 years
275.31%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$21.81B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

TENET HEALTHCARE CORP Overview

View more →

(m)

(m)

SEC CIK
70318
Industry (SIC)
8062 Services-General Medical & Surgical Hospitals, NEC
Country of operation
United States
Business address
14201 DALLAS PARKWAY, DALLAS, Texas, 75254, United States
Fiscal year end
1231
Phone
469-893-2200

Similar stocks

Stock NameCountryMarket CapPE Ratio
Surgery Partners, Inc. (SGRY)United States$1.860B-24.80
Ardent Health, Inc. (ARDT)United States$1.478B17.91
COMMUNITY HEALTH SYSTEMS INC (CYH)United States$0.405B1.87
HCA Healthcare, Inc. (HCA)United States$93.934B15.49